Krystal Biotech, Inc.
KRYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $393 | $354 | $309 | $345 |
| Short-Term Investments | $338 | $328 | $308 | $253 |
| Receivables | $130 | $111 | $103 | $105 |
| Inventory | $38 | $31 | $30 | $27 |
| Other Curr. Assets | $27 | $17 | $17 | $13 |
| Total Curr. Assets | $926 | $841 | $767 | $742 |
| Property Plant & Equip (Net) | $156 | $158 | $159 | $161 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $133 | $139 | $148 | $152 |
| Tax Assets | $25 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $314 | $297 | $308 | $314 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,240 | $1,138 | $1,074 | $1,056 |
| Liabilities | – | – | – | – |
| Payables | $2 | $7 | $3 | $5 |
| Short-Term Debt | $2 | $2 | $1 | $1 |
| Tax Payable | $0 | $8 | $11 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $87 | $70 | $64 | $92 |
| Total Curr. Liab. | $91 | $87 | $79 | $102 |
| LT Debt | $8 | $8 | $8 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $2 | $1 |
| Total NC Liab. | $11 | $11 | $10 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $10 | $10 | $7 |
| Total Liabilities | $102 | $98 | $90 | $109 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$27 | -$107 | -$145 | -$181 |
| AOCI | $1 | $1 | $0 | -$0 |
| Other Equity | $1,164 | $1,146 | $1,129 | $1,127 |
| Total Equity | $1,138 | $1,041 | $985 | $946 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,240 | $1,138 | $1,074 | $1,056 |
| Net Debt | -$383 | -$344 | -$299 | -$338 |